Learn More
R&D Systems™ Human IL-21, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 8879-IL-050/CF
Description
The Recombinant Human IL-21 Protein is derived from E. coli. The Recombinant Human IL-21 Protein has been validated for the following applications: Bioactivity.Specifications
| Q9HBE4 | |
| Observed M.W.: 17kDa, reducing conditions, Theoretical M.W.: 15kDa | |
| E. coli-derived human IL-21 protein Gln25-Ser155,with a N-terminal Met | |
| <0.10 EU per 1μg of the protein by the LAL method. | |
| IL-21 | |
| Measured in a cell proliferation assay using N1186 human T cells. Parrish-Novak, J. et al. (2000) Nature 408:57. The ED50 for this effect is typically 2-12ng/mL. | |
| Yes |
| 59067 | |
| 50μg | |
| 12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. | |
| IL21, IL-21Za11interleukin-21, interleukin 21, interleukin-21 isoform | |
| IL21 | |
| Unconjugated |
Das Fisher Scientific Encompass-Programm bietet Artikel an, die nicht Teil unseres Vertriebsportfolios sind. Diese Produkte verfügen in der Regel nicht über Bilder oder detaillierte Beschreibungen. Wir sind jedoch bestrebt, Ihr Einkaufserlebnis zu verbessern. Bitte verwenden Sie das untenstehende Formular, um uns Feedback zum Inhalt dieses Produkts zu geben.